Compare MGTX & BARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGTX | BARK |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 73.7M |
| IPO Year | 2018 | 2020 |
| Metric | MGTX | BARK |
|---|---|---|
| Price | $10.73 | $8.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $27.75 | $15.50 |
| AVG Volume (30 Days) | ★ 932.8K | 46.7K |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.02 | N/A |
| EPS | ★ 1.30 | 0.08 |
| Revenue | $81,391,000.00 | ★ $394,843,000.00 |
| Revenue This Year | $314.19 | N/A |
| Revenue Next Year | N/A | $4.97 |
| P/E Ratio | ★ $8.22 | $106.50 |
| Revenue Growth | ★ 144.57 | N/A |
| 52 Week Low | $6.62 | $0.50 |
| 52 Week High | $15.35 | $11.32 |
| Indicator | MGTX | BARK |
|---|---|---|
| Relative Strength Index (RSI) | 28.57 | 36.78 |
| Support Level | $8.84 | $0.59 |
| Resistance Level | $11.85 | $9.86 |
| Average True Range (ATR) | 0.57 | 0.36 |
| MACD | -0.19 | -0.02 |
| Stochastic Oscillator | 8.18 | 11.90 |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
BARK Inc believe that dogs and humans are good together and it aspire to be the world's favorite dog brand. It is a team of dog-obsessed people committed to delivering personalization at scale by satisfying each dog's distinct personality, preferences, and needs with the products and services. It is an omnichannel brand that designs and develops proprietary products for dogs across two key brands: BarkBox and Super Chewer. All of its products are designed and developed in-house, and are BARK branded. Its segments are DTC, and Commerce. It generates majority of revenue from DTC. Direct to Consumer generates revenue from subscription products that feature monthly themes of premium quality BarkBox and Super Chewer toys and BARK-branded treats and chews.